Six Star Joint and Muscle
Natural health product licensed in Canada
- Licence holder
- Iovate Health Sciences International Inc.
- NPN or DIN-HM
- 80074494
- Status
- Active licence
- Licence date
- 15 December 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 20 µg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Salix alba L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Méthylsulfonylméthane Source : Sulfone de diméthyl | 500 milligramme | Not calculated |
| Vitamine D Source : Cholécalciférol | 133.33 UI | 19.9995 µg |
| Vitamine D Source : Cholécalciférol | 3.33 microgrammes | Not calculated |
| Salix alba Source : Jeune écorce de branche Extract : Matériel brut sec Extraction ratio : 8:1 Dry plant equivalent : 266.4 milligramme Potency : 25 % Salicin | 33.3 milligramme | Not calculated |
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Exosquelette de crevette | 250 milligramme | Not calculated |
Non-medicinal ingredients
Dioxyde de titane, Phosphate de dicalcium dihydraté, Stéarate de magnésium, Gélatine, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Capsule | 2 Tous les jours |
Uses authorised in Canada
Helps to relieve joint pain associated with osteoarthritis (of the knee). Helps to protect against the deterioration of cartilage. A factor in maintaining healthy cartilage and/or joint health. Helps to relieve (joint) pain associated with osteoarthritis (of the knee). (White willow is traditionally) used in Herbal Medicine for the relief of minor joint pain (due to osteoarthritis). Helps in the development and maintenance of bones.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If symptoms worsen, consult a health care practitioner. If you have asthma or peptic ulcer disease, consult a health care practitioner prior to use. If you are taking anticoagulants or products containing acetylsalicylic acid (ASA) or other salicylates, consult a health care practitioner prior to use.
- Contre-indications
If you are pregnant or breastfeeding, do not use this product. If you are allergic to acetylsalicylic acid (ASA) or other salicylates, do not use this product.
- Effets indésirables connus
Some people may experience mild gastrointestinal disturbances such as diarrhoea, abdominal pain, heartburn, nausea and vomiting; in which case, discontinue use.
Source
Official Health Canada record, licence 80074494
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.